{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T18:02:37Z","timestamp":1776535357880,"version":"3.51.2"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":5028,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/s1525-0016(02)00019-9","type":"journal-article","created":{"date-parts":[[2003,2,4]],"date-time":"2003-02-04T23:36:59Z","timestamp":1044401819000},"page":"122-128","source":"Crossref","is-referenced-by-count":211,"title":["Quantification of adeno-associated virus particles and empty capsids by optical density measurement"],"prefix":"10.1016","volume":"7","author":[{"given":"J.\u00fcrg M","family":"Sommer","sequence":"first","affiliation":[]},{"given":"Peter H","family":"Smith","sequence":"additional","affiliation":[]},{"given":"Sumathy","family":"Parthasarathy","sequence":"additional","affiliation":[]},{"given":"Jesse","family":"Isaacs","sequence":"additional","affiliation":[]},{"given":"Sharmila","family":"Vijay","sequence":"additional","affiliation":[]},{"given":"Jane","family":"Kieran","sequence":"additional","affiliation":[]},{"given":"Sharon K","family":"Powell","sequence":"additional","affiliation":[]},{"given":"Alan","family":"McClelland","sequence":"additional","affiliation":[]},{"given":"J.Fraser","family":"Wright","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1525-0016(02)00019-9_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1749-6632.2001.tb11361.x","article-title":"AAV-mediated gene transfer for hemophilia","volume":"953","author":"High","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/S1525-0016(02)00019-9_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.genom.2.1.177","article-title":"Gene therapy","volume":"2","author":"Pfeifer","year":"2001","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"issue":"Suppl. 1","key":"10.1016\/S1525-0016(02)00019-9_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1523-1755.2002.0610s1009.x","article-title":"Recent advances in recombinant adeno-associated virus vector production","volume":"61","author":"Clark","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/S1525-0016(02)00019-9_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/1521-2254(2000)9999:9999<::AID-JGM152>3.0.CO;2-U","article-title":"Optimised helper virus-free production of high-quality adeno-associated virus vectors","volume":"3","author":"Drittanti","year":"2001","journal-title":"J. Gene Med."},{"key":"10.1016\/S1525-0016(02)00019-9_bib5","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1089\/104303400750001390","article-title":"Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo","volume":"10","author":"Gao","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S1525-0016(02)00019-9_bib6","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1089\/10430349950016799","article-title":"Progress in adeno-associated virus type 2 vector production","volume":"10","author":"Grimm","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S1525-0016(02)00019-9_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"Maizel","year":"1968","journal-title":"Virology"},{"key":"10.1016\/S1525-0016(02)00019-9_bib8","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/S1525-0016(02)00019-9_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/viro.2002.1406","article-title":"Evaluation of accuracy and precision of adenovirus absorptivity at 260 nm under conditions of complete DNA disruption","volume":"295","author":"Sweeney","year":"2002","journal-title":"Virology"},{"key":"10.1016\/S1525-0016(02)00019-9_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0378-4347(99)00316-3","article-title":"Reversed-phase high-performance liquid chromatographic assay for the adenovirus type 5 proteome","volume":"732","author":"Lehmberg","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/S1525-0016(02)00019-9_bib11","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1128\/JVI.62.9.3356-3363.1988","article-title":"Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein","volume":"62","author":"Trempe","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/S1525-0016(02)00019-9_bib12","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1073\/pnas.162250899","article-title":"The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy","volume":"99","author":"Xie","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1525-0016(02)00019-9_bib13","unstructured":"Anders, J. (2001). Amino acid analysis. In BioPharm Guide to Bioanalytical Methods,supplement to BioPharm. Advanstar Communications"},{"key":"10.1016\/S1525-0016(02)00019-9_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0003-2697(89)90602-7","article-title":"Calculation of protein extinction coefficients from amino acid sequence data","volume":"182","author":"Gill","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1016\/S1525-0016(02)00019-9_bib15","series-title":"Fields Virology","first-page":"2173","article-title":"Parvoviridae","author":"Berns","year":"1996"},{"key":"10.1016\/S1525-0016(02)00019-9_bib16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3301527","article-title":"Development of formulations that enhance physical stability of viral vectors for gene therapy","volume":"8","author":"Croyle","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/S1525-0016(02)00019-9_bib17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.gt.3300680","article-title":"Adeno-associated virus vectors can be efficiently produced without helper virus","volume":"7","author":"Matsushita","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/S1525-0016(02)00019-9_bib18","first-page":"S50","article-title":"Characterization of AAV vectors expressing human coagulation factor IX produced at intermediate scale","volume":"5","author":"Qu","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/S1525-0016(02)00019-9_bib19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/mthe.2000.0075","article-title":"Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro","volume":"1","author":"Miao","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/S1525-0016(02)00019-9_bib20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gr.6.10.986","article-title":"Real time quantitative PCR","volume":"6","author":"Heid","year":"1996","journal-title":"Genome Res."},{"key":"10.1016\/S1525-0016(02)00019-9_bib21","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/sj.gt.3300946","article-title":"Titration of AAV-2 particles via a novel capsid ELISA","volume":"6","author":"Grimm","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/S1525-0016(02)00019-9_bib22","unstructured":"Cantor, C. R., and Schimmel, P. R. (1980). Biophysical chemistry, part II. In Techniques for the Study of Biological Structure and Function. Freeman, San Francisco"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001602000199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001602000199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T08:02:20Z","timestamp":1584000140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001602000199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S1525001602000199"],"URL":"https:\/\/doi.org\/10.1016\/s1525-0016(02)00019-9","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}